Trial Profile
Post marketing clinical trial of TJ-54 for patients who have neuropsychiatric symptoms of Parkinson`s disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Jun 2016
Price :
$35
*
At a glance
- Drugs TJ 54 (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Tsumura
- 01 Jun 2016 New trial record